Evidence map›Paper›PMID 31558890›Full record

ArticleAdvanced functional materials2018

Bioorthogonal Strategies for Engineering Extracellular Matrices.

Christopher M Madl, Sarah C Heilshorn

Abstract read
In one paragraph

Article in Advanced functional materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Engineered Protein Hydrogels as Biomimetic Cellular Scaffolds.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  14. Review
  15. Photoinduced Dithiolane Crosslinking for Multiresponsive Dynamic Hydrogels.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
  16. Article
  17. ACS nano · 2024
    Article
  18. Review
  19. Review
  20. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christopher M MadlDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Sarah C HeilshornDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA, heilshorn@stanford.edu.

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2015 to 2025
$13.5M
Engineered Protein Hydrogels to Modulate Adipose-derived Stromal Cell Secretome and Exosomes for Injectable Myocardial Infarction TherapyR21HL138042 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2017 to 2018
$435k
Injectable Hydrogels to Improve the Efficacy of iPSC-derived TherapiesR21EB020235 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2015 to 2016
$433k
Cell Responsive Hydrogels to Improve Functional Recovery after Spinal Cord InjuryF31EB020502 · NIBIB · STANFORD UNIVERSITY · PI MADL, CHRISTOPHER MATTHEW · 2015 to 2016
$69k
NHLBI NIH HHS R21 HL138042NIAID NIH HHS U19 AI116484NIBIB NIH HHS F31 EB020502NIBIB NIH HHS R21 EB020235
6 · The paper itself

Abstract

Hydrogels are commonly used as engineered extracellular matrix (ECM) mimics in applications ranging from tissue engineering to

Indexed as

biomaterialsbio-orthogonal chemistrydynamic materialsengineered extracellular matrixhydrogels

Identifiers

PMID31558890
PMCPMC6761700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.